Search

everythinglearnresearchcommunity

for

Search:↓

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

The SBN system effectively assesses alopecia areata severity and predicts its course.

Higher IL-21 levels may help predict alopecia areata activity.

Higher CRBP1 levels are linked to more severe alopecia areata.

Lower vitamin D levels are linked to more severe alopecia areata.

Carcinosin, a homeopathic remedy, helped a young girl with alopecia areata regrow hair and reduce psychological symptoms.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Pix Liquida may help treat alopecia areata.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib may help treat severe hair loss, but more research is needed.

Baricitinib is effective and safe for treating severe alopecia areata.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

AI can accurately measure hair loss severity in alopecia areata.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.